Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants

JAMA

Volumn 307, Issue 3, 2012, Pages 283-293

  Feng, Sandy ^a   Ekong, Udeme D ^b   Lobritto, Steven J ^c   Demetris, Anthony J ^d   Roberts, John P ^a   Rosenthal, Philip ^a   Alonso, Estella M ^b   Philogene, Mary C ^e   Ikle, David ^g   Poole, Katharine M ^g   Bridges, Nancy D ^h   Turka, Laurence A ^e,f   Tchao, Nadia K ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e Immune Tolerance Network   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g RHO INC   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D;

ARTICLE; AUTOIMMUNE DISEASE; BILE DUCT ATRESIA; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SCREENING TEST; TRANSPLANTATION TOLERANCE; TREATMENT WITHDRAWAL; VIRUS HEPATITIS; CLINICAL TRIAL; GRAFT REJECTION; HOSPITALIZATION; LIVER; LIVER CIRRHOSIS; METHODOLOGY; PARENT; PATIENT SELECTION; PHYSIOLOGY; TREATMENT OUTCOME;

CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INFANT; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PARENTS; PATIENT SELECTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84855993116     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.2014     Document Type: Article

References (30)

1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med. 2003; 348(17):1681-1691. (Pubitemid 36459475)
2. Del Compare ME,D'Agostino D, Ferraris JR, Boldrini G, Waisman G, Krmar RT. Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients. Pediatr Transplant. 2004;8(5):496-501. (Pubitemid 39279021)
3. Fredericks EM, Lopez MJ, Magee JC, Shieck V, Opipari-Arrigan L. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation. Am J Transplant. 2007;7(8):1974-1983. (Pubitemid 47037988)
4. Traum AZ, Kawai T, Vacanti JP, Sachs DH, Cosimi AB, Madsen JC. The need for tolerance in pediatric organ transplantation. Pediatrics. 2008;121(6): 1258-1260.
5. Assy N, Adams PC, Myers P, et al. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. Transplantation. 2007;83(12):1571-1576. (Pubitemid 46987908)
6. Devlin J, Doherty D, Thomson L, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology. 1998;27(4):926-933. (Pubitemid 28160476)
7. Eason JD, Cohen AJ, Nair S, Alcantera T, Loss GE. Tolerance: is it worth the risk? Transplantation. 2005; 79(9):1157-1159. (Pubitemid 40664015)
8. Koshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation. Transpl Immunol. 2007;17(2): 94-97. (Pubitemid 46240888)
9. Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation. 1997;63(2):243-249. (Pubitemid 27121206)
10. Pons JA, Yélamos J, Ramírez P, et al. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation. 2003;75 (7):1045-1047. (Pubitemid 36438536)
11. Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation. 1995;59(2):212-217.
12. Sandborn WJ, Hay JE, Porayko MK, et al. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection. Hepatology. 1994;19(4): 925-932. (Pubitemid 24109355)
13. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993; 17(6):1127-1152. (Pubitemid 23187422)
14. Takatsuki M, Uemoto S, Inomata Y, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation. 2001;72(3):449-454. (Pubitemid 32769631)
15. Tisone G, Orlando G, Cardillo A, et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006; 44(4):702-709.
16. Tryphonopoulos P, Tzakis AG, Weppler D, et al. The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant. 2005;5(3): 608-613. (Pubitemid 40313354)
17. Demetris AJ, Lunz JG III, Randhawa P, Wu T, Nalesnik M, Thomson AW. Monitoring of human liver and kidney allograft tolerance: a tissue/ histopathology perspective. Transpl Int. 2009; 22(1):120-141.
18. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25(3):658-663.
19. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection: an international panel. Hepatology. 2000; 31(3):792-799. (Pubitemid 30118655)
20. Bray RA, Lebeck LK, Gebel HM. The flow cytometric crossmatch: dual-color analysis of T cell and B cell reactivities. Transplantation. 1989;48(5):834-840. (Pubitemid 19284373)
21. Vaidya S. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Transplantation. 2008;85(7): 1046-1050. (Pubitemid 351543170)
22. Isse K, Lesniak A, Grama K, Roysam B, Minervini MI, Demetris AJ. Digital transplantation pathology: combining whole slide imaging, multiplex staining and automated image analysis [published online November 4, 2011]. Am J Transplant. doi:10.1111/j.1600-6143.2011.03797.x.
23. Mazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: long term results and future prospects. Transpl Immunol. 2007;17(2):114-119. (Pubitemid 46240885)
24. Long E, Wood KJ. Regulatory T cells in transplantation: transferring mouse studies to the clinic. Transplantation. 2009;88(9):1050-1056.
25. Martínez-Llordella M, Puig-Pey I,Orlando G, et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant. 2007; 7(2):309-319. (Pubitemid 46096324)
26. Wong T, Nouri-Aria KT, Devlin J, Portmann B, Williams R. Tolerance and latent cellular rejection in long-term liver transplant recipients. Hepatology. 1998; 28(2):443-449. (Pubitemid 28363672)
27. Colvin RB. Dimensions of antibody-mediated rejection. Am J Transplant. 2010;10(7):1509-1510.
28. Bellamy CO, Herriot MM, Harrison DJ, Bathgate AJ. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology. 2007;50(6):739-749. (Pubitemid 46683930)
29. Martelius T, Halme L, Arola J, Höckerstedt K, Lautenschlager I. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection. Transpl Immunol. 2009;21(4):244-246.
30. Troxell ML, Higgins JP, Kambham N. Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med. 2006;130(10):1489-1496. (Pubitemid 44520715)